Paper8995940
Long course and prognostic factors of virus-induced cirrhosis of the liver.
Gentilini P and 10 others. Am J Gastroenterol, 1997. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Long course and prognostic factors of virus-induced cirrhosis of the liver. Papers, record 8995940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8995940
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis C | Major topic |
| Liver Cirrhosis | Major topic |
| Bilirubin | |
| Carcinoma, Hepatocellular | |
| Chronic Disease | |
| Esophageal and Gastric Varices | |
| Female | |
| Follow-Up Studies | |
| Gastrointestinal Hemorrhage | |
| Hepatic Encephalopathy | |
| Humans | |
| Jaundice | |
| Liver Neoplasms | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40929456 | COMPARING THE PREDICTIVE EFFICACY OF MELD AND ALBI SCORES IN LIVER CIRRHOSIS PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING. | Arq Gastroenterol | 2025 | https://conductscience.org/library/papers/40929456 | PubMed |
| 38947874 | Lobe-Based Hepatic Uptake Index of Gd-EOB-DTPA on Contrast-Enhanced MRI to Quantitatively Discriminate between Compensated and Decompensated Hepatitis B-Related Cirrhosis. | Can J Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38947874 | PubMed |
| 37538247 | Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease. | JHEP Rep | 2023 | https://conductscience.org/library/papers/37538247 | PubMed |
| 36908849 | Emerging Therapeutic Targets for Portal Hypertension. | Curr Hepatol Rep | 2023 | https://conductscience.org/library/papers/36908849 | PubMed |
| 36498435 | The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36498435 | PubMed |
| 32385703 | Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong. | Dig Dis Sci | 2021 | https://conductscience.org/library/papers/32385703 | PubMed |
| 31936470 | Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany. | Int J Environ Res Public Health | 2020 | https://conductscience.org/library/papers/31936470 | PubMed |
| 31215410 | Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis. | BMC Gastroenterol | 2019 | https://conductscience.org/library/papers/31215410 | PubMed |
| 30622374 | Quality of life in patients with minimal hepatic encephalopathy. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/30622374 | PubMed |
| 30564001 | Current Diagnosis and Classification of Hepatic Encephalopathy. | J Clin Exp Hepatol | 2018 | https://conductscience.org/library/papers/30564001 | PubMed |
| 29507462 | The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. | Ann Gastroenterol | 2018 | https://conductscience.org/library/papers/29507462 | PubMed |
| 29325277 | [Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis]. | Zhonghua Gan Zang Bing Za Zhi | 2017 | https://conductscience.org/library/papers/29325277 | PubMed |
| 27910116 | The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) subjects treated with all-oral elbasvir/grazoprevir regimens in the United States. | Aliment Pharmacol Ther | 2017 | https://conductscience.org/library/papers/27910116 | PubMed |
| 26937441 | State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. | Eur J Radiol Open | 2015 | https://conductscience.org/library/papers/26937441 | PubMed |
| 24616574 | Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24616574 | PubMed |
| 24057240 | Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. | Mol Biol Rep | 2013 | https://conductscience.org/library/papers/24057240 | PubMed |
| 24041347 | Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States. | Value Health | 2013 | https://conductscience.org/library/papers/24041347 | PubMed |
| 23621902 | Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study. | BMC Infect Dis | 2013 | https://conductscience.org/library/papers/23621902 | PubMed |
| 23376840 | Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23376840 | PubMed |
| 21063479 | Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. | Hepatol Int | 2010 | https://conductscience.org/library/papers/21063479 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8995940
GET https://conductscience.org/api/papers/v1/8995940/cited_by?page=2